General Information of Target

Target ID LDTP01872
Target Name Interleukin-1 beta (IL1B)
Gene Name IL1B
Gene ID 3553
Synonyms
IL1F2; Interleukin-1 beta; IL-1 beta; Catabolin
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKG
FRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVR
SLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKE
KNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYIST
SQAENMPVFLGGTKGGQDITDFTMQFVSS
Target Type
Successful
Target Bioclass
Cytokine and receptor
Family
IL-1 family
Subcellular location
Cytoplasm, cytosol
Function
Potent pro-inflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production. Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (Th1) cells. Plays a role in angiogenesis by inducing VEGF production synergistically with TNF and IL6. Involved in transduction of inflammation downstream of pyroptosis: its mature form is specifically released in the extracellular milieu by passing through the gasdermin-D (GSDMD) pore. Acts as a sensor of S.pyogenes infection in skin: cleaved and activated by pyogenes SpeB protease, leading to an inflammatory response that prevents bacterial growth during invasive skin infection.
TTD ID
T42000
Uniprot ID
P01584
DrugMap ID
TTBJZ7D
Ensemble ID
ENST00000263341.7
HGNC ID
HGNC:5992
ChEMBL ID
CHEMBL1909490

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 3 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C124(0.69)  LDD3312  [1]
BTD
 Probe Info 
C124(0.67)  LDD2120  [2]
IPM
 Probe Info 
C124(2.10)  LDD1701  [2]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0213  Electrophilic fragment 2 MDA-MB-231 C124(1.57)  LDD1702  [2]
 LDCM0022  KB02 A101D C124(3.83)  LDD2250  [1]
 LDCM0023  KB03 MDA-MB-231 C124(2.10)  LDD1701  [2]
 LDCM0024  KB05 HMCB C124(0.69)  LDD3312  [1]
 LDCM0527  Nucleophilic fragment 26b MDA-MB-231 C124(0.67)  LDD2120  [2]
 LDCM0549  Nucleophilic fragment 43 MDA-MB-231 C124(0.98)  LDD2143  [2]

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
2 Nucleophilic covalent ligand discovery for the cysteine redoxome. Nat Chem Biol. 2023 Nov;19(11):1309-1319. doi: 10.1038/s41589-023-01330-5. Epub 2023 May 29.
Mass spectrometry data entry: PXD039908 , PXD029761